AQR Capital Management
TPST icon

AQR Capital Management’s Tempest Therapeutics TPST Stock Holding History

AQR Capital Management’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11
Closed -$277K – 2308
2015
Q3 		$277K Sell
11
-3
-21% -$202K ﹤0.01% 1948
2015
Q2 		$1.16M Buy
14
+4
+40% +$366K ﹤0.01% 1426
2015
Q1 		$965K Buy
10
+3
+43% +$399K ﹤0.01% 1432
2014
Q4 		$907K Buy
+7
New +$513K ﹤0.01% 1697

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
OH
Orbis Holdings Hamilton, Bermuda $12.8B AUM 8.29% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AQR Capital Management's TPST Position: Q4 2015 in Review

AQR Capital Management sold out of Tempest Therapeutics (TPST) in Q4 2015, closing a stake of 11 shares — an estimated $277K sold.

AQR Capital Management first reported a position in TPST in Q4 2014 and held it in 4 quarters. The position peaked at $1.16M in Q2 2015. 78 funds tracked by Wall St. Rank hold TPST as of Q4 2015.

  • AQR Capital Management reported no remaining Tempest Therapeutics position as of Q4 2015 after selling out during the quarter.
  • AQR Capital Management sold 11 Tempest Therapeutics shares in Q4 2015, an estimated $277K.
  • AQR Capital Management first reported a position in Tempest Therapeutics in Q4 2014 and held it in 4 quarters.
  • AQR Capital Management's Tempest Therapeutics position peaked at $1.16M in Q2 2015.
  • 78 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2015.

Based on AQR Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.